Errata
- PMID: 32755509
- PMCID: PMC7402999
- DOI: 10.1200/JCO.20.01943
Errata
Erratum for
-
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study.J Clin Oncol. 2020 Jun 1;38(16):1814-1823. doi: 10.1200/JCO.19.02059. Epub 2020 Apr 10. J Clin Oncol. 2020. PMID: 32275468 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources